The Scientific Team at Mediar Therapeutics is responsible for advancing the company's antibody-based therapies from discovery through preclinical development. The team, composed of scientists and advisors with expertise in pharmacology, clinical translational medicine, and antibody engineering, works collaboratively to investigate the efficacy, safety, and mechanism of action of potential treatments for fibrosis in various organ systems.